The Gross Law Firm notifies investors that a class action has commenced in the United States District Court for the District of Delaware on behalf of shareholders of Humana Inc. who purchased Common stock between July 27, 2022 and January 24, 2024.
According to the filed complaint, defendants made false and/or misleading statements and/or failed to disclose that: Specifically, defendants downplayed pressures on the Company’s adjusted earnings per share, resulting from increased medical costs associated with pent-up demand for healthcare procedures which contrary to the Company’s assurances, resulted in increased utilization rates and costs.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action. Appointment as Lead Plaintiff is not required to partake in any recovery.
Shareholders have until August 2, 2024 to request that the court appoint them lead plaintiff.
To receive more information, please fill out the form.
